share_log

Moderna | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Moderna | S-8:員工福利計劃證券登記

SEC announcement ·  02/24 05:28
牛牛AI助理已提取核心訊息
Moderna, Inc. has filed a new registration statement with the Securities and Exchange Commission (SEC) on February 23, 2024. The Form S-8 registration statement pertains to the registration of an additional 15,271,788 shares of common stock under the company's 2018 Stock Option and Incentive Plan. This registration is a result of an automatic annual increase provision within the plan. The additional shares are of the same class as those previously registered under the 2018 Plan, and the contents of the original 2018 Registration Statement have been incorporated by reference. The filing includes various exhibits, such as the opinion of Goodwin Procter LLP and the consent of Ernst & Young LLP, Moderna's independent registered public accounting firm. The CEO of Moderna, Stéphane Bancel, along with other executives and directors, have signed the registration statement, confirming their belief that the company meets all requirements for the filing.
Moderna, Inc. has filed a new registration statement with the Securities and Exchange Commission (SEC) on February 23, 2024. The Form S-8 registration statement pertains to the registration of an additional 15,271,788 shares of common stock under the company's 2018 Stock Option and Incentive Plan. This registration is a result of an automatic annual increase provision within the plan. The additional shares are of the same class as those previously registered under the 2018 Plan, and the contents of the original 2018 Registration Statement have been incorporated by reference. The filing includes various exhibits, such as the opinion of Goodwin Procter LLP and the consent of Ernst & Young LLP, Moderna's independent registered public accounting firm. The CEO of Moderna, Stéphane Bancel, along with other executives and directors, have signed the registration statement, confirming their belief that the company meets all requirements for the filing.
Moderna, Inc. 已於2024年2月23日向美國證券交易委員會(SEC)提交了新的註冊聲明。S-8表格註冊聲明涉及根據公司2018年股票期權和激勵計劃另外註冊15,271,788股普通股。這種登記是計劃中每年自動增加條款的結果。新增股份與先前在2018年計劃下注冊的股票屬於同一類別,原始2018年註冊聲明的內容已通過引用方式納入。該文件包括各種證據,例如古德溫·寶潔律師事務所的意見和Moderna獨立註冊會計師事務所安永會計師事務所的同意。Moderna首席執行官斯特凡·班塞爾以及其他高管和董事簽署了註冊聲明,證實了他們認爲該公司符合所有申請要求的信念。
Moderna, Inc. 已於2024年2月23日向美國證券交易委員會(SEC)提交了新的註冊聲明。S-8表格註冊聲明涉及根據公司2018年股票期權和激勵計劃另外註冊15,271,788股普通股。這種登記是計劃中每年自動增加條款的結果。新增股份與先前在2018年計劃下注冊的股票屬於同一類別,原始2018年註冊聲明的內容已通過引用方式納入。該文件包括各種證據,例如古德溫·寶潔律師事務所的意見和Moderna獨立註冊會計師事務所安永會計師事務所的同意。Moderna首席執行官斯特凡·班塞爾以及其他高管和董事簽署了註冊聲明,證實了他們認爲該公司符合所有申請要求的信念。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。